That's essential, since the method a protein in the body folds identifies if a pharmaceutical will have the ability to bind to that protein and work. In other words, we have to know how these proteins fold if we want a drug to work. Historically, this has been a trial-and-error procedure (brownstone research stock). Today, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it a lot easier to create drugs that do what they're designed to do. This was a breakthrough almost nobody discovered. However it's going to have extensive ramifications for treating disease. I anticipate that Alpha, Fold will be 98% precise by the end of 2021.
And, naturally, there will be a lot of financial investment opportunities in this area, too. Shifting topics It's going to be a great year for bitcoin. I'm bullish on it in 2021 (future report). That stated, I still believe bitcoin will continue to be unpredictable. We're close to all-time highs. I would not be amazed if it drew back perhaps considerably prior to going greater - jeff brown stock predictions 2021. I've been covering bitcoin for a very long time now. Among the first research study reports I ever published was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that initial recommendation, I entitled my report "What's the Big Deal With Bitcoin?" That shows you where the conversation was at the time. We were primarily educating readers. However that's not the huge question anymore. Now we're seeing institutional money finally take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, specific niche enterprise. Mass, Mutual is a trusted 170-year-old organization. So think of that. In 5 years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
Which's a huge reason I'm bullish on it this year. jeff brown genome sequencing stock. Regards, Jeff Brown, Editor, The Bleeding Edge I have a reward forecast 2020 was a record year for IPOs. 552 U.S. business went public the most in more than twenty years. These business raised an overall of $172 billion. That's an all-time high beating the previous yearly record by 43%. I forecast 2021 will be another record year in IPOs. There are a lot of terrific private business on the edge of hitting the general public markets And I've been working on a brand-new method for you to invest even prior to these business go public.
This chance has been developing over the last couple of years. I can't wait to tell you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to learn all the details. Go right here to reserve your area for totally free.
Emma Walsh here, managing editor of the Journal. Routine Diary readers know that tech isn't our typical beat (jeff brown biotech stocks). And when it comes to tech investing, we leave it to the specialists. The good news is, we have numerous such experts in our Rolodex. Our colleague Jeff Brown will be familiar to our longtime readers. He is among the most accomplished tech investing specialists we understand (jeff brown genome sequencing stock). In reality, he had numerous triple-digit returns in his Brownstone Research study portfolios in 2015. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to take an appearance at the huge image and anticipate what's just around the corner.
That includes things like 5G networks, biotech, synthetic intelligence, and a lot more. These trends are experiencing rapid development and creating amazing chances for financiers. I wish to make sure all our readers are prepared for what's next. And with that in mind, let me draw the picture of what I see coming in the next 12 months Our new 5G (fifth-generation) cordless networks are a topic I've been covering for years now. genetic sequencing companies jeff brown. But despite what lots of readers may believe, this is a trend that's simply getting started. Despite the fact that the COVID-19 pandemic interrupted supply chains last year, an impressive 250 million 5G-enabled devices were still offered.
And all of this ultimately caused Apple delaying the release of the 5G-enabled i, Phone 12 by two months (tech stocks). Losing two months of manufacturing and sales truly impacts the number of 5G gadgets are offered in the calendar year. When you think about all of that, offering 250 million systems is impressive. More significantly, the hold-ups triggered by the pandemic created a lots of pent-up need. And that demand is now going to be pushed into 2021. In reality, I predict that more than 500 million 5G gadgets will be shipped in 2021 - jeff brown prediction for 2021. Which's not my only 5G prediction When I have actually spoken about 5G in the past, I have actually explained its 3 various phases.
In Stage Two, 5G gadgets go on sale. 5G phones and other items start to reach customers. And in Phase Three, 5G services begin to be provided (jeff brown 2021 stock picks). That's when we start to see applications working on 5G networks. Consider things like massive multiplayer video games over a smart phone. That's not possible with 4G. It will be with 5G. And my 2nd 5G forecast for 2021 is that we will begin Phase Three by this summer season. This starts something of a virtuous cycle: The majority of individuals do not really appreciate the innovation. But they will care if there are interesting applications that can only be accessed with a 5G phone.
That causes more 5G apps being developed. In fact, 5G is going to open up a suite of amazing applications: self-driving cars, the Web of Things, robotic surgical treatment, and more. All of these innovations require 5G. The financial investment opportunities moving forward will be enormous. Stepping far from 5G, the next important innovation I anticipate in 2021 is CRISPR genetic editing. CRISPR means "clustered frequently interspaced short palindromic repeat." It's a mouthful. But it's one of the most amazing advancements in biotechnology. At a high level, CRISPR is an innovation that can modify our genetic makeup as if it were software application.
The program can crash or not function correctly. CRISPR uses a similar concept but with our genetic code. "Typos" in our genome can result in disease. CRISPR can remedy these "typos." For years, CRISPR was primarily a specific niche technology that wasn't well understood. And throughout that time, there were actually just three companies running in this area. But things are altering. CRISPR is no longer just theoretical. We're seeing actual outcomes. We're dealing with illness and seeing that this innovation just works. And as a result, a "2nd crop" of early-stage CRISPR business is going public and delivering amazing returns. This whole market is efficiently a greenfield chance.
There's space for many companies to exist in this area. brownstone research stock. And there will be more. That's my forecast for CRISPR in 2021. I forecast that 2 or 3 more hereditary editing business will hold their IPOs. Sticking to biotechnology, we are seeing fantastic things occurring at the merging of biotech and synthetic intelligence (AI). Google's AI subsidiary, Deep, Mind, just revealed at the end of 2020 that its newest Alpha, Fold software application can properly forecast the folding of a protein based exclusively on its amino acid series with 92. 4% accuracy. That is essential since the way a protein in the body folds identifies if a pharmaceutical will have the ability to bind to that protein and be reliable.
Historically, this has been an experimental procedure. But now, Alpha, Fold can predict protein folding with 92. 4% precision. That's going to make it much easier to develop drugs that do what they're designed to do. And here's my next forecast. I forecast that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not just one however a number of drug therapies produced using this technology. This was one of those advancements that practically no one saw. However it's going to have profound implications for curing disease. And, of course, there will be plenty of financial investment chances in this area, too.
It's going to be an excellent year for bitcoin. I'm bullish on it in 2021. That stated, I still believe bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be amazed if it pulled back maybe significantly prior to going higher. I've been covering bitcoin for a long time now. Among the first research study reports I ever released was on bitcoin - angel investor. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on financial investment for anybody who followed my recommendation. But at the time of that initial recommendation, I entitled my report, "What's the Big Offer With Bitcoin?" That reveals you where the discussion was at the time.
But no one is asking that question any longer. Now, we're seeing institutional cash finally taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, niche business. bleeding edge. Mass, Mutual is a 150-year-old organization. So believe about that. In five years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a huge reason that I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another bonus offer prediction In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown is worth about $27. 5 million and declares the information depends on date as of February 2021, but we could not separately confirm this claim. Offered Jeff Brown's past, he likely has a considerable net worth, however we can't hammer down an exact figure at this moment. Brown is best understood for his sage-like ability to pick winning innovation stocks. He spent more than 25 years looking into technology business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's extensive experience provides him an exceptional perspective on the marketplace. He's constantly on the hunt for brand-new opportunities, and he shares a lot of his best picks in the Near Future Report.
That's high praise, however it's not ridiculously reasoned. Brown has an exceptional track record as a stock-picker, and he effectively anticipated a few of the most significant financial occasions of the previous 20 years. Although he doesn't appear to release his choices to the public, the service's success is a direct indication of Brown's stock-picking prowess. No one on Wall Street gets it ideal every time, however Jeff Brown's accurate forecasts have made him legions of dedicated followers. That states a lot about his capability. The Near Future Report is released by Brownstone Research, a prominent financial research study publisher. Brownstone Research offers several research services with a variety of specializations - biotech stock.
The company is likewise connected with Bonner & Partners, another well-respected research study publisher - white house. On its site, Brownstone says its objective is to supply retail investors with professional-grade research study: "For too long, the best investment research study has actually not been available to private financiers. It has been normally booked for investment banks, hedge funds, private equity, and high-net-worth clients. diplomatic relations. The objective of Brownstone Research is to make that type of exclusive research study available to any investors aiming to gain an edge in the markets. The objective is basic to deliver distinct and successful investment research study found no place else." -Brownstone Research study site excerpt from the Jeff Brown is the founder of Brownstone Research, and he also serves as the firm's Chief Financial investment Expert.
With Brown guiding the ship, Brownstone Research study is a powerhouse publisher with lots to use its customers. After years of stable success at the helm of top-tier business like Tesla and Space, X, Elon Musk is a family name throughout the majority of America. If you understand even a little bit about the market, you understand that he has a track record as a King Midas of sorts. jeff bezos. Whatever he touches turns to gold! Jeff is well aware of Elon Musk's executive expertise, so he always has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next huge project.
In reality, Brown thinks S.A.V. jeff brown 2021 predictions. might be "the greatest trend of the 2020s, and he's not alone. Have a look at these quotes from other popular S.A.V. bulls: Elon's next big act will be weding 2 innovative innovations: expert system and electrical automobiles. Musk hopes the combination will help him establish the very first fully-autonomous, self-driving vehicles ever. It's nothing except the vehicle industry's Holy Grail. As you understand, electrical vehicles and self-driving vehicle stocks have been big this year, however the Wall Street maker has actually been big on hype without much tangible outcome. In spite of an extreme increase in competition over the past couple of years, Brown still believes Musk has the finest chance of putting everything together.
tech might be the magic string that connects all of it together. S.A.V. represents Shared Autonomous Car, and it might be the future of transportation. Generally, this innovation would permit you to lease out your car as a self-governing, self-driving taxi when you're not utilizing it. You merely leave the automobile and press a button on an app that informs the car to "join the fleet." Next thing you know, you're unwinding on your sofa while your car shuttles ride-sharers around town. Best of all, you get to keep a substantial portion of the earnings. It sounds outrageous, but it might be closed than you think.